<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD 2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">EXCLI J</journal-id>
      <journal-title>EXCLI Journal</journal-title>
      <issn pub-type="epub">1611-2156</issn>
      <publisher>
        <publisher-name>Leibniz Research Centre for Working Environment and Human Factors</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">2022-4889</article-id>
      <article-id pub-id-type="doi">10.17179/excli2022-4889</article-id>
      <article-id pub-id-type="pii">Doc888</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Tryptophan recovery index as a new biomarker for fitness</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Pichler</surname>
            <given-names>Alexander</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Meinitzer</surname>
            <given-names>Andreas</given-names>
          </name>
          <xref ref-type="corresp" rid="COR1">&#x0002a;</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Enko</surname>
            <given-names>Dietmar</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Schober</surname>
            <given-names>Peter</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Singer</surname>
            <given-names>Georg</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Castellani</surname>
            <given-names>Christoph</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Herrmann</surname>
            <given-names>Markus</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Holasek</surname>
            <given-names>Sandra J.</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Till</surname>
            <given-names>Holger</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Windhaber</surname>
            <given-names>Jana Maria</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>Division of General Anesthesiology, Emergency - and Intensive Care Medicine, Medical University of Graz, Graz, Austria</aff>
      <aff id="A2">
        <label>2</label>Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria</aff>
      <aff id="A3">
        <label>3</label>Department of Pediatric and Adolescent Surgery, Medical University of Graz, Graz, Austria</aff>
      <aff id="A4">
        <label>4</label>Division of Immunology and Pathophysiology, Otto Loewi Research Center, Medical University of Graz, Graz, Austria</aff>
      <author-notes>
        <corresp id="COR1">*To whom correspondence should be addressed: Andreas Meinitzer, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Auenbruggerplatz 34, Medical University of Graz, A-8036 Graz, Austria; Phone: +43/316/385-83988, Fax: +43/316/385-13419, E-mail: <email>andreas.meinitzer@medunigraz.at</email></corresp>
      </author-notes>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>06</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2022</year>
      </pub-date>
      <volume>21</volume>
      <fpage>888</fpage>
      <lpage>896</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>03</month>
          <year>2022</year>
        </date>
        <date date-type="accepted">
          <day>20</day>
          <month>06</month>
          <year>2022</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2022 Pichler et al.</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Licence (http://creativecommons.org/licenses/by/4.0/) You are free to copy, distribute and transmit the work, provided the original author and source are credited.</p>
        </license>
      </permissions>
      <self-uri xlink:href="https://www.excli.de/vol21/excli2022-4889.pdf">This article is available from https://www.excli.de/vol21/excli2022-4889.pdf</self-uri>
      <abstract><p>The maximal oxygen uptake (VO<sub>2</sub>max) and maximal power output (P<sub>max</sub>) are commonly used parameters to evaluate the endurance fitness status. A connection between exercise and the kynurenine pathway (KP), which describes the metabolism of unused tryptophan, has already been reported. However, a potential association of the KP with endurance fitness levels remains unknown. In this study, adolescent competitive athletes performed an exhaustive incremental exercise test. Blood samples were taken before, directly after, and 30 minutes after the end of exercise. Tryptophan (Trp), kynurenine (Kyn) and kynurenic acid (KA) serum levels were determined by high-performance liquid chromatography (HPLC). Forty-four male and 27 female athletes (median age: 16 years) were recruited. During exhaustive exercise tests, Trp initially declined and then increased 30 minutes after discontinuing exercise. Similar findings were observed for Kyn, whereas KA levels behaved inversely. After incremental exhaustive exercise the relative increase of Trp concentrations, termed the tryptophan-recovery-index (TRI), showed a highly significant positive correlation with VO<sub>2</sub>max and P<sub>max </sub>(r&#x3D;0.468 and 0.491, p-values &#x3C;0.001). There was a significant gender-difference with higher levels of all metabolites at all measured time points in male participants. In the present study, a highly significant correlation was found between the TRI and the maximal oxygen uptake in well-trained athletes. The implementation of TRI can therefore be suggested as a biomarker for physical fitness. </p></abstract>
      <kwd-group>
        <kwd>tryptophan</kwd>
        <kwd>kynurenine</kwd>
        <kwd>kynurenic acid</kwd>
        <kwd>kynurenine pathway</kwd>
        <kwd>exercise</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title><p>The evaluation of fitness is a much-debated topic not only amongst sports medicine specialists, but also in popular science. While the ideal fitness parameter depends on the kind of sport, the maximal oxygen uptake (VO<sub>2</sub>max) and the maximal power output (P<sub>max</sub>) during an exhaustive incremental exercise test are commonly used markers. Beside these the aerobic and anaerobic threshold are also frequently applied.</p><p>Recently, different authors investigated a possible connection between exercise and the kynurenine pathway (KP) (Martin et al., 2020[<xref ref-type="bibr" rid="R18">18</xref>]). This pathway describes the metabolism of approximately 90-99 &#x25; of the unused essential amino acid tryptophan (Trp) (Palego et al., 2016[<xref ref-type="bibr" rid="R23">23</xref>]; Richard et al., 2009[<xref ref-type="bibr" rid="R25">25</xref>]; Stone and Darlington, 2002[<xref ref-type="bibr" rid="R27">27</xref>]). The first enzymes of the KP are the tryptophan-2,3-dioxygenase (TDO) and different subtypes of the indoleamine-2,3-dioxygenase (IDO) (Chen and Guillemin, 2009[<xref ref-type="bibr" rid="R7">7</xref>]; Ball et al., 2007[<xref ref-type="bibr" rid="R5">5</xref>]), which metabolize Trp to kynurenine (Kyn). Since the main stimulator of IDO is interferon-&#x3B3; (IFN-&#x3B3;), the expression and activity of IDO are strongly related to inflammatory processes (Chen and Guillemin, 2009[<xref ref-type="bibr" rid="R7">7</xref>]; Grant et al., 2000[<xref ref-type="bibr" rid="R11">11</xref>]). Consequently, changes in the KP have been described in a variety of diseases (Nagy et al., 2017[<xref ref-type="bibr" rid="R22">22</xref>]), also including psychiatric disorders, such as depression (Chen and Guillemin, 2009[<xref ref-type="bibr" rid="R7">7</xref>]; Song et al. 2017[<xref ref-type="bibr" rid="R26">26</xref>]). While exercise is thought to be beneficial in individuals with mental disorders, it was supposed that the mood enhancing effects of exercise could be caused by changes of the KP (Allison et al., 2019[<xref ref-type="bibr" rid="R3">3</xref>]; Agudelo et al., 2019[<xref ref-type="bibr" rid="R2">2</xref>]).</p><p>Results of previously published studies examining exercise related alterations of the KP are inconsistent. Data have shown a decrease of Trp while Kyn mostly remained unchanged. Currently, the exercise induced kinetics of KA are poorly investigated (Metcalfe et al., 2018[<xref ref-type="bibr" rid="R20">20</xref>]). It is not fully understood yet, why the KP changes after exercise and how exercise can influence the KP. While many authors described a higher activity of KP-enzymes (Strasser et al., 2016[<xref ref-type="bibr" rid="R28">28</xref>][<xref ref-type="bibr" rid="R29">29</xref>]; Ito et al., 2003[<xref ref-type="bibr" rid="R14">14</xref>]; Koliamitra et al., 2019[<xref ref-type="bibr" rid="R16">16</xref>]) a shift of KP-metabolites into other body compartments could be another explanation for the metabolic kinetics (Areces et al., 2015[<xref ref-type="bibr" rid="R4">4</xref>]). In trained athletes, a permanent adaptation of the KP can be hypothesized. As a consequence, it may be possible to deduce the fitness level by investigating alterations of the KP. This is of great interest, considering that there is no biochemical parameter available, which can estimate somebody&#x27;s fitness level. </p><p>Therefore, the aim of the present study was to investigate possible associations between the kinetics of Trp metabolites and fitness parameters. We studied adolescent trained athletes during incremental exhaustive exercise testing for changes in the KP. The main focus of this study was on the recovery efficiency. </p></sec>
    <sec sec-type="materials|methods">
      <title>Materials and Methods</title><sec><title>Study population and exercise testing</title><p>A total of 71 athletes (44 males, 27 females) were included in this study after written informed consent of the patient or the legal guardian. The inclusion criteria were athletes aged between 14 and 18 years, visiting the outpatient clinic for a voluntary performance review. Each study participant underwent a clinical examination for the suitability of a physical load (12-lead ECG), determination of the resting heart rate (Assy Cam 14&#xAE;, GE Healthcare, Chicago, Illinois, USA), resting blood pressure (oscillatory, Boso Medicus&#xAE;, BOSCH&#x2B;SOHN, Jungingen, Germany), physical examination, an estimation of the total body fat (Caliper, John Bull, British Indicators Ltd., St Albans, UK) (Jackson and Pollock, 1978[<xref ref-type="bibr" rid="R15">15</xref>]), and a history of the accomplished training. Athletes were excluded from the study in case of incomplete study parameters. </p><p>An exhaustive incremental exercise protocol was performed on a bicycle ergometer (Excalibur Sport&#xAE;, Lode, Groningen, Netherlands). During the test, we recorded a 12-lead ECG and a continuous spirometry (both Jaeger Oxycon Pro&#x2122;, Hoechberg, Germany), and a pulse oximetry (BCI&#xAE; Autocorr&#xAE; Pulse Oximeter, Minneapolis, USA). Blood was drawn from an indwelling venous cannula before (t<sub>1</sub>), immediately after the exhaustive incremental exercise test (t<sub>2</sub>), and after a 30 minutes recovery period (t<sub>3</sub>). </p><p>Ethical approval was provided by the local Ethical Committee 27-406 ex 14&#x2F;15. The study was performed according to the declaration of Helsinki. Informed written consent was provided by all participants. </p></sec><sec><title>Analysis of KP key metabolites</title><p>Blood samples were drawn with 2.8 mL standard serum tubes (<italic>Vacuette&#xAE;</italic>, <italic>Greiner Bio-One</italic>, Kremsm&#xFC;nster, Austria) and were allowed to clot for 30 minutes. After centrifugation at 4000 x g for 10 minutes, 1 mL serum portions of the supernatant were harvested and stored at -80 &#xB0;C until further evaluation.</p><p>Trp, Kyn and KA were measured by high-performance liquid chromatography (HPLC) coupled with a simultaneous ultraviolet and fluorometric detection system (Herv&#xE9; et al., 1996[<xref ref-type="bibr" rid="R12">12</xref>]; Xiao et al., 2008[<xref ref-type="bibr" rid="R30">30</xref>]). All evaluations were performed according to the published guidelines (FDA, 2018[<xref ref-type="bibr" rid="R10">10</xref>]). Within-day coefficients of variation (CVs) at different concentrations were in the range between 1.7 &#x25; to 4.3 &#x25; for Kyn, 0.7 &#x25; to 2.9 &#x25; for Trp and 2.6 &#x25; to 4.5 &#x25; for KA. The between-day CVs were 2.0 &#x25; to 5.4 &#x25;, 6.3 &#x25; to 9.3 &#x25;, and 8.4 &#x25; to 11.6 &#x25;, respectively. </p></sec><sec><title>Statistical analysis </title><p>Non-normally distributed data were displayed as medians and interquartile ranges (IQR). Correlation analyses between parameters were performed using a Spearman&#x27;s rho (&#x3C1;) test. For comparison of independent groups (gender differences) a Mann-Whitney-U-test was applied. Differences between dependent variables (KP kinetics) were examined with a Friedmann-test. In case of significant results a pairwise comparison with a Wilcoxon-test followed by the Bonferroni-Holm correction for multiple testing was performed. Associations between parameters were calculated with simple linear regression model. P-values &#x3C;0.05 were regarded as statistically significant. Statistical analysis was performed with SPSS&#xAE; Statistics 22 (<italic>IBM&#xAE;,</italic> Armonk, USA).</p><p>Tryptophan recovery index (TRI), kynurenine recovery index (KRI) and kynurenic acid recovery index (KARI) were calculated by the following formulae:</p><p><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EXCLI-21-888-i-001" ></inline-graphic></p></sec></sec>
    <sec sec-type="results">
      <title>Results</title><sec><title>Study population characteristics</title><p>A total of 71 athletes (44 males, 27 females) with a median age of 16 (range: 14-18) years were examined. Detailed data for the participants are given in Table 1<xref ref-type="fig" rid="T1">(Tab. 1)</xref>. Median concentrations of Trp, Kyn and KA at t<sub>1</sub> were significantly higher in men compared to women (Trp: 70.3 vs. 60.3 &#xB5;mol&#x2F;L, p&#x3D;0.004; Kyn: 3.06 vs. 2.66 &#xB5;mol&#x2F;L, p&#x3C;0.001; KA: 47.1 vs. 39.9 nmol&#x2F;L, p&#x3D;0.005). </p></sec><sec><title>Exercise induced KP kinetics</title><p>Independently from sex, Trp and Kyn concentrations significantly decreased after exhaustive effort (t<sub>2</sub> vs. t<sub>1</sub>), while KA significantly increased (all p-values &#x2264;0.001). At t<sub>3</sub> Trp and Kyn concentrations increased (all p-values &#x3C;0.001) while KA (p&#x3C;0.001) decreased significantly compared to t<sub>2</sub>. At t<sub>3</sub>, Trp was still significantly lower (p&#x3C;0.001 in men and p&#x3D;0.003 in women) than at t<sub>1</sub>. However, there was no significant change between Kyn concentrations between these points of time. Only in men, KA concentrations were significantly increased at t<sub>3</sub> compared to t<sub>1</sub> (p &#x3C; 0.001). The kinetic of Trp blood concentrations is demonstrated in Figure 1<xref ref-type="fig" rid="F1">(Fig. 1)</xref>.</p></sec><sec><title>Correlations between kinetics of KP metabolites with fitness parameters</title><p>After incremental exhaustive exercise the relative increase of Trp concentrations (TRI) showed a highly significant positive correlation with VO<sub>2</sub>max and P<sub>max </sub>(r&#x3D;0.468 and 0.491, p-values &#x3C;0.001). The correlations of VO<sub>2</sub>max and P<sub>max </sub>were stronger in female (r&#x3D;0.713 and 0.794, p-values &#x3C;0.001) than in male athletes (r&#x3D;0.429 and r&#x3D;0.452, p&#x3D;0.004 and p&#x3D;0.002). A significant positive correlation between the relative increase of Kyn concentrations (KRI) and fitness parameters (VO<sub>2</sub>max and P<sub>max</sub>) (r&#x3D;0.433 and 0.581, p&#x3D; 0.024 and p&#x3D;0.001) was observed in females, only. No significant correlation was found between the relative decrease of KA (KARI) and fitness parameters. Detailed results of the TRI are shown in Table 2<xref ref-type="fig" rid="T2">(Tab. 2)</xref> and Figure 2<xref ref-type="fig" rid="F2">(Fig. 2)</xref>. The anonymized raw data of the present study are provided in Supplementary data (Table 1). </p></sec></sec>
    <sec sec-type="discussion">
      <title>Discussion</title><p>In this study, we found a strong correlation between the increase of Trp concentrations after exercise and fitness parameters in adolescent athletes. To the best of our knowledge, this is the first study describing the ratio of Trp concentrations immediately and 30 minutes after exercise in correlation to the fitness parameters VO<sub>2</sub>max and P<sub>max</sub>. This ratio, called TRI, describes the recovery efficiency of Trp. </p><p>We observed a decrease of Trp after exercise, which is in line with previous studies in animals and humans (Metcalfe et al., 2018[<xref ref-type="bibr" rid="R20">20</xref>]; Strasser et al., 2016[<xref ref-type="bibr" rid="R28">28</xref>][<xref ref-type="bibr" rid="R29">29</xref>]; Areces et al., 2015[<xref ref-type="bibr" rid="R4">4</xref>]; Mudry et al., 2016[<xref ref-type="bibr" rid="R21">21</xref>]; Lewis et al., 2010[<xref ref-type="bibr" rid="R17">17</xref>]; Bansi et al., 2018[<xref ref-type="bibr" rid="R6">6</xref>]; Melancon et al., 2014[<xref ref-type="bibr" rid="R19">19</xref>]). In rats, Ito et al. observed a mean decrease of 43.5 &#x25; of blood Trp concentrations after treadmill exercise with exhaustion (Ito et al., 2003[<xref ref-type="bibr" rid="R14">14</xref>]). Mudry et al. found slightly decreased Trp levels in diabetic patients and healthy controls after 30 min training compared to baseline concentrations (Mudry et al., 2016[<xref ref-type="bibr" rid="R21">21</xref>]). Also in athletes Trp declined after exhaustive exercise (Strasser et al., 2016[<xref ref-type="bibr" rid="R28">28</xref>][<xref ref-type="bibr" rid="R29">29</xref>]), even during ultramarathon running (Yamada et al., 2016[<xref ref-type="bibr" rid="R31">31</xref>]). In our study, we observed a decline of Kyn after exercise. In contrast to Trp, contradicting results have been published regarding Kyn alterations after exercise. Data from Yamada et al. (2016[<xref ref-type="bibr" rid="R31">31</xref>]) are consistent with our findings. They found a decrease of Kyn after 35 km ultramarathon running. However, other authors describe an increase of Kyn after exercise (Strasser et al., 2016[<xref ref-type="bibr" rid="R28">28</xref>][<xref ref-type="bibr" rid="R29">29</xref>]; Mudry et al., 2016[<xref ref-type="bibr" rid="R21">21</xref>]; Ito et al., 1999[<xref ref-type="bibr" rid="R13">13</xref>]). Contrary to Trp and Kyn, we found a distinct increase (approximately 40 &#x25;) of KA after exercise. Little data are available about alterations of KA after exercise. Our findings confirm one previously published study (Mudry et al., 2016[<xref ref-type="bibr" rid="R21">21</xref>]). </p><p>Nevertheless, the explanation for alterations of Trp and KP metabolites during and after exercise is an emerging topic of current discussions. Previous studies reported a shift of amino acids due to exercise from the vascular compartment into skeletal muscle (Strasser et al., 2016[<xref ref-type="bibr" rid="R29">29</xref>]; Areces et al., 2015[<xref ref-type="bibr" rid="R4">4</xref>]). This shift may be facilitated by an enhanced expression of the large amino acid transporter 1 (LAT1), which carries Trp into skeletal muscle (Martin et al., 2020[<xref ref-type="bibr" rid="R18">18</xref>]; Pillon et al., 2020[<xref ref-type="bibr" rid="R24">24</xref>]). A higher physiological energy consumption in skeletal muscle could be one possible explanation for the observed Trp kinetics for energy production (Agudelo et al., 2019[<xref ref-type="bibr" rid="R2">2</xref>]). Moreover, during exercise, the PPAR-&#x3B3; coactivator-1&#x3B1;1 (PGC-1&#x3B1;1) enhances the expression of kynurenine-amino-transferases (KATs) in skeletal muscle elevating the production of KA (Agudelo et al., 2019[<xref ref-type="bibr" rid="R2">2</xref>]; Agudelo et al., 2014[<xref ref-type="bibr" rid="R1">1</xref>]). Subsequently, more KA is shifted from skeletal muscle into the circulation (Martin et al., 2020[<xref ref-type="bibr" rid="R18">18</xref>]). This theory is in line with our data showing a Kyn decrease and KA elevation after exercise. Allison et al. showed that a 12-week exercise program increases the expression of skeletal muscle transcription factors PGC-1&#x3B1;, PPAR&#x3B1; and PPAR&#x3B4;, but they did not see an effect on the kynurenine metabolism (Allison et al., 2019[<xref ref-type="bibr" rid="R3">3</xref>]).</p><p>We found a strong association between the TRI and the conventional fitness parameters. In comparison Strasser et al. described a positive correlation between the maximal oxygen consumption (VO<sub>2</sub>max) and values of Trp (Strasser et al., 2016[<xref ref-type="bibr" rid="R29">29</xref>]). However, they did neither assess the association between the rebound of Trp after a recovery period nor the fitness status. </p><p>It is well known that physical exercise activates the coactivator PGC-1&#x3B1;1, a master coactivator of cellular adaptive processes, which improves fuel supply, uptake and utilization (Correia et al., 2015[<xref ref-type="bibr" rid="R8">8</xref>]), but also the expression of KATs (Agudelo et al., 2014[<xref ref-type="bibr" rid="R1">1</xref>]). The increased activity of the KATs might lead to higher blood glutamate concentrations, which are important for energy utilization. Moreover, the PGC-1&#x3B1;1 regulated pathway in the trained muscle is considered to use Kyn as a supporter for aspartate biosynthesis and mitochondrial function (Agudelo et al., 2019[<xref ref-type="bibr" rid="R2">2</xref>]). It might be possible that in trained athletes this pathway is gained. After exercise the no longer needed Trp and Kyn is shifted back faster into the vascular compartment in better trained athletes. Therefore, the TRI is higher in these individuals. </p><p>Male athletes had a higher VO<sub>2</sub>max compared to female athletes, which correspond with the higher baseline values of the KP. This gender difference was already discussed in prior studies (Strasser et al., 2016[<xref ref-type="bibr" rid="R29">29</xref>]). It was suggested that estrogen and progesterone activate the KP downstream (de Bie et al., 2016[<xref ref-type="bibr" rid="R9">9</xref>]). However, we found significantly higher Trp, Kyn and KA in men, which partly is in line with a previous report describing higher Kyn blood concentrations in men, but no differences in other KP metabolites (Strasser et al., 2016[<xref ref-type="bibr" rid="R29">29</xref>]). Another study of the same study group reported lower Kyn levels in women (Strasser et al., 2016[<xref ref-type="bibr" rid="R28">28</xref>]). In contrast to conventional fitness parameters, the TRI might give information about the individual fitness status independently from sex. </p><p>Further studies are required to optimize the predictive value of the TRI including duration and degree of the necessary exercise, duration of observation and recovery. If it is possible to determine the TRI in a simple way, it could be a valuable parameter to evaluate the fitness status.</p><p>Some limitations of this study should be mentioned. The last meal before blood taking was not standardized due to comfort for our athletes. This circumstance could have an influence on the baseline values of Trp metabolism. Moreover, inflammatory markers, such as interleukin-6 (IL-6) or cortisol were not assessed. </p></sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title><p>In the present study, a highly significant correlation could be found between the TRI and the maximal oxygen uptake in well-trained athletes. The authors of this study suggest to use the TRI as a biomarker for physical fitness.  </p></sec>
    <sec>
      <title>Conflict of interest</title><p>The authors declare that there is no conflict of interest.</p></sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <supplementary-material id="SD1" content-type="local-data">
        <caption>
          <title>Supplementary data</title>
        </caption>
        <media mimetype="application" mime-subtype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xlink:href="EXCLI-21-888-s-001.xlsx" />
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Agudelo</surname>
              <given-names>LZ</given-names>
            </name>
            <name>
              <surname>Femenia</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Orhan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Porsmyr-Palmertz</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Goiny</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Martinez-Redondo</surname>
              <given-names>V</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Skeletal muscle PGC-1alpha1 modulates kynurenine metabolism and mediates resilience to stress-induced depression</article-title>
          <source>Cell</source>
          <year>2014</year>
          <volume>159</volume>
          <fpage>33</fpage>
          <lpage>45</lpage>
        </citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Agudelo</surname>
              <given-names>LZ</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>DMS</given-names>
            </name>
            <name>
              <surname>Dadvar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Cervenka</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Ketscher</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Izadi</surname>
              <given-names>M</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Skeletal muscle PGC-1alpha1 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance</article-title>
          <source>Nat Commun</source>
          <year>2019</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>2767</fpage>
        </citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Allison</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Nederveen</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Snijders</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Bell</surname>
              <given-names>KE</given-names>
            </name>
            <name>
              <surname>Kumbhare</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>SM</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Exercise training im-pacts skeletal muscle gene expression related to the kynurenine pathway</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2019</year>
          <volume>316</volume>
          <fpage>C444</fpage>
          <lpage>C4C8</lpage>
        </citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Areces</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Gonzalez-Millan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Salinero</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Abian-Vicen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lara</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Gallo-Salazar</surname>
              <given-names>C</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Changes in serum free amino acids and muscle fatigue experienced during a half-ironman triathlon</article-title>
          <source>PLoS One</source>
          <year>2015</year>
          <volume>10</volume>
          <issue>9</issue>
          <fpage>e0138376</fpage>
        </citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Ball</surname>
              <given-names>HJ</given-names>
            </name>
            <name>
              <surname>Sanchez-Perez</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weiser</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Austin</surname>
              <given-names>CJ</given-names>
            </name>
            <name>
              <surname>Astel-bauer</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Miu</surname>
              <given-names>J</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice</article-title>
          <source>Gene</source>
          <year>2007</year>
          <volume>396</volume>
          <fpage>203</fpage>
          <lpage>213</lpage>
        </citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Bansi</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Koliamitra</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Bloch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Joisten</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Schenk</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>M</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Persons with secondary progressive and relapsing remitting multiple sclerosis reveal dif-ferent responses of tryptophan metabolism to acute endurance exercise and training</article-title>
          <source>J Neuroimmunol</source>
          <year>2018</year>
          <volume>314</volume>
          <fpage>101</fpage>
          <lpage>105</lpage>
        </citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Chen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Guillemin</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Kynurenine pathway metabo-lites in humans: disease and healthy States</article-title>
          <source>Int J Tryptophan Res</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>1</fpage>
          <lpage>19</lpage>
        </citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Correia</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Ruas</surname>
              <given-names>JL</given-names>
            </name>
          </person-group>
          <article-title>Intercellular: local and systemic actions of skeletal muscle PGC-1s</article-title>
          <source>Trends Endocrinol Metab</source>
          <year>2015</year>
          <volume>26</volume>
          <fpage>305</fpage>
          <lpage>314</lpage>
        </citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>de Bie</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Guillemin</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Kynurenines, gender and neuroinflammation;showcase schizophrenia</article-title>
          <source>Neurotox Res</source>
          <year>2016</year>
          <volume>30</volume>
          <fpage>285</fpage>
          <lpage>294</lpage>
        </citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <citation citation-type="book">
          <collab>FDA, Food and Drug Administration, U.S. Department of Health and Human Services, FDA, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM)</collab>
          <source>Bioanalytical method validation - guidance for industry</source>
          <year>2018</year>
          <publisher-loc>Rockeville, MA</publisher-loc>
          <publisher-name>FDA</publisher-name>
        </citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Grant</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Naif</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Espinosa</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kapoor</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>IDO induc-tion in IFN-gamma activated astroglia: a role in im-proving cell viability during oxidative stress</article-title>
          <source>Redox Rep</source>
          <year>2000</year>
          <volume>5</volume>
          <fpage>101</fpage>
          <lpage>104</lpage>
        </citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Herv&#xE9;</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Beyne</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jamault</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Delacoux</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection</article-title>
          <source>J Chromatogr B Biomed Appl</source>
          <year>1996</year>
          <volume>675</volume>
          <fpage>157</fpage>
          <lpage>161</lpage>
        </citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Maruta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nakagami</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ogu-ri</surname>
              <given-names>Y</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Kynurenine concentration of serum was in-creased by exercise</article-title>
          <source>Adv Exp Med Biol</source>
          <year>1999</year>
          <volume>467</volume>
          <fpage>717</fpage>
          <lpage>722</lpage>
        </citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Ito</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yonekura</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Maruta</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Koike</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Nakagami</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>K</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Tryptophan metabolism was accelerated by exercise in rat</article-title>
          <source>Adv Exp Med Biol</source>
          <year>2003</year>
          <volume>527</volume>
          <fpage>531</fpage>
          <lpage>535</lpage>
        </citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Jackson</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Pollock</surname>
              <given-names>ML</given-names>
            </name>
          </person-group>
          <article-title>Generalized equations for predicting body density of men</article-title>
          <source>Br J Nutr</source>
          <year>1978</year>
          <volume>40</volume>
          <fpage>497</fpage>
          <lpage>504</lpage>
        </citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Koliamitra</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Javelle</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Joisten</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shimabukuro-Vornhagen</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bloch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Schenk</surname>
              <given-names>A</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Do acute exercise-induced activations of the kynurenine pathway induce regulatory T-cells on the long-term&#x3F; - A theoretical frame work supported by pilot data</article-title>
          <source>J Sports Sci Med</source>
          <year>2019</year>
          <volume>18</volume>
          <fpage>669</fpage>
          <lpage>673</lpage>
        </citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Lewis</surname>
              <given-names>GD</given-names>
            </name>
            <name>
              <surname>Farrell</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Martinovic</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arany</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Rowe</surname>
              <given-names>GC</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Metabolic signatures of exercise in human plasma</article-title>
          <source>Sci Transl Med</source>
          <year>2010</year>
          <volume>2</volume>
          <issue>33</issue>
          <fpage>33ra7</fpage>
        </citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Martin</surname>
              <given-names>KS</given-names>
            </name>
            <name>
              <surname>Azzolini</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lira Ruas</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>The kynurenine connection: how exercise shifts muscle tryptophan metabolism and affects energy homeostasis, the im-mune system, and the brain</article-title>
          <source>Am J Physiol Cell Physiol</source>
          <year>2020</year>
          <volume>318</volume>
          <fpage>C818</fpage>
          <lpage>CC30</lpage>
        </citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Melancon</surname>
              <given-names>MO</given-names>
            </name>
            <name>
              <surname>Lorrain</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dionne</surname>
              <given-names>IJ</given-names>
            </name>
          </person-group>
          <article-title>Changes in markers of brain serotonin activity in response to chronic exercise in senior men</article-title>
          <source>Appl Physiol Nutr Metab</source>
          <year>2014</year>
          <volume>39</volume>
          <fpage>1250</fpage>
          <lpage>1256</lpage>
        </citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Metcalfe</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Koliamitra</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Javelle</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Bloch</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Zim-mer</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Acute and chronic effects of exercise on the kynurenine pathway in humans - A brief review and future perspectives</article-title>
          <source>Physiol Behav</source>
          <year>2018</year>
          <volume>194</volume>
          <fpage>583</fpage>
          <lpage>587</lpage>
        </citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Mudry</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Alm</surname>
              <given-names>PS</given-names>
            </name>
            <name>
              <surname>Erhardt</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Goiny</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fritz</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Caidahl</surname>
              <given-names>K</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Direct effects of exercise on kynurenine metabolism in people with normal glucose tolerance or type 2 diabetes</article-title>
          <source>Diabetes Metab Res Rev</source>
          <year>2016</year>
          <volume>32</volume>
          <fpage>754</fpage>
          <lpage>761</lpage>
        </citation>
      </ref>
      <ref id="R22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Nagy</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Nagaraj</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Meinitzer</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Papp</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Foris</surname>
              <given-names>V</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Importance of kynurenine in pulmo-nary hypertension</article-title>
          <source>Am J Physiol Lung Cell Mol Physiol</source>
          <year>2017</year>
          <volume>313</volume>
          <fpage>L741</fpage>
          <lpage>LL51</lpage>
        </citation>
      </ref>
      <ref id="R23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Palego</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Betti</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Rossi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Giannaccini</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Tryptophan biochemistry: structural, nutritional, metabolic, and medical aspects in humans</article-title>
          <source>J Amino Acids</source>
          <year>2016</year>
          <volume>2016</volume>
          <fpage>8952520</fpage>
        </citation>
      </ref>
      <ref id="R24">
        <label>24</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Pillon</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>Gabriel</surname>
              <given-names>BM</given-names>
            </name>
            <name>
              <surname>Dollet</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>JAB</given-names>
            </name>
            <name>
              <surname>Sardon Puig</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Botella</surname>
              <given-names>J</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Transcriptomic profiling of skeletal muscle adaptations to exercise and inactivity</article-title>
          <source>Nat Commun</source>
          <year>2020</year>
          <volume>11</volume>
          <issue>1</issue>
          <fpage>470</fpage>
        </citation>
      </ref>
      <ref id="R25">
        <label>25</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Richard</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Dawes</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Mathias</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Acheson</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hill-Kapturczak</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Dougherty</surname>
              <given-names>DM</given-names>
            </name>
          </person-group>
          <article-title>L-Tryptophan: basic metabolic functions, behavioral research and therapeutic indications</article-title>
          <source>Int J Tryptophan Res</source>
          <year>2009</year>
          <volume>2</volume>
          <fpage>45</fpage>
          <lpage>60</lpage>
        </citation>
      </ref>
      <ref id="R26">
        <label>26</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Song</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Ramprasath</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Zou</surname>
              <given-names>MH</given-names>
            </name>
          </person-group>
          <article-title>Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases</article-title>
          <source>Cell Mol Life Sci</source>
          <year>2017</year>
          <volume>74</volume>
          <fpage>2899</fpage>
          <lpage>2916</lpage>
        </citation>
      </ref>
      <ref id="R27">
        <label>27</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Stone</surname>
              <given-names>TW</given-names>
            </name>
            <name>
              <surname>Darlington</surname>
              <given-names>LG</given-names>
            </name>
          </person-group>
          <article-title>Endogenous kynurenines as targets for drug discovery and development</article-title>
          <source>Nat Rev Drug Discov</source>
          <year>2002</year>
          <volume>1</volume>
          <fpage>609</fpage>
          <lpage>620</lpage>
        </citation>
      </ref>
      <ref id="R28">
        <label>28</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Strasser</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Geiger</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schauer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gatterer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burtscher</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fuchs</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Effects of exhaustive aerobic exercise on tryptophan-kynurenine metabolism in trained athletes</article-title>
          <source>PLoS One</source>
          <year>2016</year>
          <volume>11</volume>
          <issue>4</issue>
          <fpage>e0153617</fpage>
        </citation>
      </ref>
      <ref id="R29">
        <label>29</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Strasser</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Geiger</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Schauer</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gostner</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Gatterer</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burtscher</surname>
              <given-names>M</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Probiotic supplements benefi-cially affect tryptophan-kynurenine metabolism and reduce the incidence of upper respiratory tract infections in trained athletes: a randomized, double-blinded, placebo-controlled trial</article-title>
          <source>Nutrients</source>
          <year>2016</year>
          <volume>8</volume>
          <issue>11</issue>
          <fpage>752</fpage>
        </citation>
      </ref>
      <ref id="R30">
        <label>30</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Xiao</surname>
              <given-names>LD</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>XB</given-names>
            </name>
            <name>
              <surname>Pi</surname>
              <given-names>LG</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>AG</given-names>
            </name>
          </person-group>
          <article-title>Simultaneous de-termination of kynurenine and kynurenic acid concentrations in human serum by HPLC with dual wavelengths fluorescence detection</article-title>
          <source>Clin Chim Acta</source>
          <year>2008</year>
          <volume>395</volume>
          <fpage>178</fpage>
          <lpage>180</lpage>
        </citation>
      </ref>
      <ref id="R31">
        <label>31</label>
        <citation citation-type="journal">
          <person-group>
            <name>
              <surname>Yamada</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shibata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fuku</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kuriki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Goto</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Tokudome</surname>
              <given-names>Y</given-names>
            </name>
            <etal />
          </person-group>
          <article-title>Changes of tryptophan metabolism in Japanese runners during an ultra-marathon race</article-title>
          <source>Sport Sci Health</source>
          <year>2016</year>
          <volume>12</volume>
          <issue>1</issue>
          <fpage>77</fpage>
          <lpage>83</lpage>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="T1" position="float">
      <label>Table 1</label>
      <caption><title>Anthropometric and biochemical characteristics of participants</title></caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EXCLI-21-888-t-001" />
    </fig>
    <fig id="T2" position="float">
      <label>Table 2</label>
      <caption><title>Simple linear regression of TRI, KRI and KARI with fitness parameters</title></caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EXCLI-21-888-t-002" />
    </fig>
    <fig id="F1" position="float">
      <label>Figure 1</label>
      <caption><title>Exercise induced kinetic of Trp blood concentrations before (t1), immediately after an exhaustive incremental exercise test (t2), and after 30 minutes of recovery (t3). </title><p>&#x2A;&#x2A;p&#x3D;0.003; &#x2A;&#x2A;&#x2A;p&#x3C;0.001</p></caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EXCLI-21-888-g-001" />
    </fig>
    <fig id="F2" position="float">
      <label>Figure 2</label>
      <caption><title>Simple linear regression analysis between tryptophan-recovery-inex and P<sub>max</sub> in all (N&#x3D;71) (A), female (N&#x3D;27) (B), and male athletes (N&#x3D;44) (C)</title></caption>
      <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="EXCLI-21-888-g-002" />
    </fig>
  </floats-wrap>
</article>